Edap Tms (NASDAQ:EDAP) Shares Pass Above 200 Day Moving Average – Here’s Why

Edap Tms S.A. (NASDAQ:EDAP) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $1.92 and traded as high as $2.16. Edap Tms shares last traded at $2.10, with a volume of 21,673 shares traded.

Analysts Set New Price Targets

A number of research firms have commented on EDAP. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Edap Tms in a report on Thursday. Jefferies Financial Group restated a “hold” rating and issued a $2.00 price target on shares of Edap Tms in a research report on Thursday, November 6th. One analyst has rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $8.50.

Edap Tms Trading Down 0.9%

The company has a debt-to-equity ratio of 0.04, a current ratio of 1.51 and a quick ratio of 1.05. The firm’s fifty day moving average price is $2.29 and its 200-day moving average price is $1.92. The company has a market cap of $78.52 million, a price-to-earnings ratio of -3.44 and a beta of -0.18.

Edap Tms (NASDAQ:EDAP) last posted its earnings results on Thursday, November 6th. The medical equipment provider reported ($0.15) EPS for the quarter, topping the consensus estimate of ($0.26) by $0.11. Edap Tms had a negative net margin of 33.49% and a negative return on equity of 56.85%. The firm had revenue of $18.75 million during the quarter, compared to analysts’ expectations of $15.05 million. On average, equities analysts expect that Edap Tms S.A. will post -0.6 EPS for the current fiscal year.

Institutional Investors Weigh In On Edap Tms

Several institutional investors have recently bought and sold shares of EDAP. Sage Mountain Advisors LLC acquired a new position in Edap Tms during the 2nd quarter valued at about $165,000. Simplicity Wealth LLC acquired a new position in shares of Edap Tms during the second quarter valued at approximately $54,000. Banque Transatlantique SA lifted its position in Edap Tms by 7,063.7% in the first quarter. Banque Transatlantique SA now owns 730,699 shares of the medical equipment provider’s stock worth $1,324,000 after purchasing an additional 720,499 shares during the period. Scoggin Management LP bought a new position in Edap Tms during the 1st quarter valued at $686,000. Finally, Cetera Investment Advisers increased its position in shares of Edap Tms by 33.9% during the 1st quarter. Cetera Investment Advisers now owns 75,000 shares of the medical equipment provider’s stock valued at $147,000 after purchasing an additional 19,000 shares during the period. Institutional investors and hedge funds own 62.74% of the company’s stock.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.